Craig C. Hopkinson
EVP R&D, Chief Medical Officer · 3 filings · Latest: Jun 1, 2026
Alkermes plc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 1, 2026 | Sale | $41.67 | 9,000 | $375.0K | 77,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 86,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | May 1, 2026 | Sale | $33.40 | 9,000 | $300.6K | 81,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | May 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 90,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Apr 1, 2026 | Sale | $35.51 | 9,000 | $319.6K | 85,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Apr 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 94,389 |